Tirosinemia tipo I: dos formas atípicas de presentación clínica

作者: N. Lambruschini Ferri , M. Arellano , A. Ribes , R. García-Romero , J.A. Arranz Amo

DOI:

关键词:

摘要: Resumen Se exponen dos casos de tirosinemia tipo I con presentacion atipica. El primero se inicia crisis convulsivas secundarias a hipoglucemias graves. En el estudio metabolico para diag-nostico las detecta un perfil tipico ti-rosinemia en sangre y orina. segundo caso fue hallazgo casual contexto ingreso por bronquitis. Ambos siguen tratamiento 2-(2-nitro-4-trifluorome-tilbenzoil)-1-3-ciclohexanediona (NTBC) combinacion dieta bajo contenido proteinas naturales suplementada formula especial sin tirosina ni fenilalanina. la actua-lidad no presentan alteraciones clinico-analiticas compli-caciones. Palabras clave Tirosinemia, tirosina, NTBC Abstract Title: Tyrosinemia type I: two atypical forms of clinical presentationThe authors describe cases tyrosinemia with aty-pical presentation. The first patient presented refrac-tory seizures secondary to hypoglycemic episodes. metabolic study for the differential diagnosis hypoglycemia, revealed pattern suggestive I. In second patient, presence was detected during hospital stay owing bronchitis. both cases, treatment 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione combined low protein diet supplemented tyrosine- and phen-ylalanine-free prescribed. There have been com-plications follow-up period in either case and, at present time, analytical findings are normal.

参考文章(15)
J. Ros, M. A. Vilaseca, N. Lambruschini>, A. Mas, S. Lindstedt, E. Holme, NTBC as palliative treatment in chronic tyrosinaemia type I. Journal of Inherited Metabolic Disease. ,vol. 22, pp. 665- 666 ,(1999) , 10.1023/A:1005594416973
Arden K, Tanguay Rm, Cavenee W, Labelle Y, Bérubé D, Gagné R, Phaneuf D, Cloning and expression of the cDNA encoding human fumarylacetoacetate hydrolase, the enzyme deficient in hereditary tyrosinemia: assignment of the gene to chromosome 15. American Journal of Human Genetics. ,vol. 48, pp. 525- 535 ,(1991)
P. Gissen, M. A. Preece, H. A. Willshaw, P. J. McKiernan, Ophthalmic follow-up of patients with tyrosinaemia type I on NTBC Journal of Inherited Metabolic Disease. ,vol. 26, pp. 13- 16 ,(2003) , 10.1023/A:1024011110116
E. Holme, S. Lindstedt, Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione). Journal of Inherited Metabolic Disease. ,vol. 21, pp. 507- 517 ,(1998) , 10.1023/A:1005410820201
Pierre A. Russo, Grant A. Mitchell, Robert M. Tanguay, Tyrosinemia: A Review Pediatric and Developmental Pathology. ,vol. 4, pp. 212- 221 ,(2001) , 10.1007/S100240010146
C Perez‐Cerda, B Merinero, P Sanz, M Castro, J Gangoiti, MJ Garcia, M Díaz, E Medina, M Ugarte, None, Liver transplantation in nine Spanish patients with tyrosinaemia type I. Journal of Inherited Metabolic Disease. ,vol. 18, pp. 119- 122 ,(1995) , 10.1007/BF00711744
Francjan J. van Spronsen, Charles M. A. Bijleveld, Bianca T. van Maldegem, Frits A. Wijburg, Hepatocellular carcinoma in hereditary tyrosinemia type I despite 2-(2 nitro-4-3 trifluoro- methylbenzoyl)-1, 3-cyclohexanedione treatment Journal of Pediatric Gastroenterology and Nutrition. ,vol. 40, pp. 90- 93 ,(2005) , 10.1097/00005176-200501000-00017
Rossana Jorquera, Robert M. Tanguay, The Mutagenicity of the Tyrosine Metabolite, Fumarylacetoacetate, Is Enhanced by Glutathione Depletion Biochemical and Biophysical Research Communications. ,vol. 232, pp. 42- 48 ,(1997) , 10.1006/BBRC.1997.6220
J. Ros Viladoms, M.aA. Vilaseca Buscà, N. Lambruschini Ferri, A. Mas Comas, E. González Pascual, E. Holme, Evolución de un caso de tirosinemia crónica tipo I tratado con NTBC Anales De Pediatria. ,vol. 54, pp. 305- 309 ,(2001) , 10.1016/S1695-4033(01)77531-5